IRCCS INRCA Hospital
Ancona, 60127, Italy
NCT Number: NCT06640452
The scope of the RecoveryFun study is to test a new personalised home rehabilitation solution to leverage the telehealth paradigm and increase the possibility for seniors to perform remotely supervised home-rehabilitation.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Ancona, 60127, Italy
This study was designed to test the usability and acceptability of the RecoveryFun system by a group of subjects, aged 60 years or older, within one year after an acute event with upper limb hemiplegia (Fugl- Meyer > 33). The patient, once the acute and intensive phase of rehabilitation is over, should also continue from home the process begun. However, this often creates difficulties for the patient. The study was carried out at the three recruitment sites (ZURZACH Care, TRAINM and INRCA)
The study was structured in two phases:
The two phases had different specific objectives and to avoid any bias due to previous experience the participants recruited in the two phases were different.
The RecoveryFun system comprehended Three tools: a Virtual reality headset for rehabilitation purposes, a set of Exergames and an app installed on caregiver's smartphone to motivate and support the end user in the therapy. The clinical personnel had access to the Clinical platform provided as a secured web app. The system administrator could differentiate access rights to each clinical user group (e.g: doctors, physiotherapists, nurses). An Innovative biosensing wireless sensor (wristband) was integrated in the connected ecosystem to measure physiological parameters (Heart Rate and Electrodermal Activity) of end users during the rehabilitation session. The patient performed the rehabilitation session according to the rehabilitation plan defined by the clinician. To have coherent results the rehabilitation plan included at least two weekly rehabilitation sessions lasting between 10 and 30 minutes, with the support of the caregiver, if necessary. Each session was planned and scheduled by the therapist remotely via the dedicated clinical platform.
After 4 weeks the assessment of usability and acceptability of the RecoveryFun system were performed by validated tools.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The system components were: VR headset; wereable biosensors, clinical platform, caregiver app and smart services.
Time frame: after 4 weeks of home-rehabilitation with RecoveryFun system
The usability was assessed by the System Usability Scale (SUS). The SUS is a 10 item questionnaire with 5 response options.It generates a quantifiable measure called the SUS score, which ranges from 0 to 100, with zero being the least and 100 being the maximum.
Time frame: after 4 weeks of home-rehabilitation with RecoveryFun system
The acceptability was assessed by the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST). The QUEST is a 12-item outcome measure that assesses user satisfaction with two components, Device and Services. The questionnaire consists of 12 satisfaction items.
Istituto Nazionale di Ricovero e Cura per Anziani
Other
Acronym: RECOVERYFUN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05402007
Behavior, Exercises
Rio de Janeiro, Brazil
View Trial DetailsNCT07729124
Behavior, Brain Damage, Chronic
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT06499272
Alzheimer Disease, Brain Diseases
Madrid, Spain
View Trial DetailsNCT03926520
Aberrant Motor Behavior in Dementia, Agitation,Psychomotor
Atlanta, Georgia, United States
View Trial Details